PsoBest - The German Psoriasis Registry
Long-Term Benefits and Safety of Systemic Psoriasis Therapy: German Registry on the Treatment of Psoriasis With Biologics and Systemic Therapeutics
Sponsor: AbbVie
A observational or N/A phase clinical study on Psoriasis and Psoriatic-arthritis, this trial is actively recruiting participants. The trial is conducted by AbbVie and has accumulated 12 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Jun 2025 — Present [monthly]
Recruiting
-
Feb 2025 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 7 earlier versions
-
Jun 2022 — May 2023 [monthly]
Recruiting
-
Jan 2021 — Jun 2022 [monthly]
Recruiting
-
Jun 2019 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Nov 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Nov 2017 [monthly]
Recruiting NA
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AbbVie
- Almirall Hermal GmbH
- Amgen
- Berufsverband der Deutschen Dermatologen e.V. (www.bvdd.de)
- Biogen
- Bristol-Myers Squibb
- Celgene
- Deutsche Dermatologische Gesellschaft e.V. (https://derma.de)
- Eli Lilly and Company
- Janssen-Cilag G.m.b.H
- LEO Pharma
- Merck Serono GmbH, Germany
- Merck Sharp & Dohme LLC
- Novartis Pharmaceuticals
- Pfizer Pharmaceuticals Ltd.
- PsoNet.eu (http://www.psonet.eu/)
- UCB Pharma
- Universitätsklinikum Hamburg-Eppendorf
- Viatris Inc.
- medac GmbH
For direct contact, visit the study record on ClinicalTrials.gov .